Erratum: Target-Driven Design of a Coumarinyl Chalcone Scaffold Based Novel EF2 Kinase Inhibitor Suppresses Breast Cancer Growth in Vivo (ACS Pharmacol. Transl. Sci. (2021) 4:2 (926-940) DOI: 10.1021/acsptsci.1c00030)